计算机视觉综合征管理干预措施的系统评价与Meta分析
该系统评价与Meta分析纳入45项随机对照试验共4497名参与者,评估与安慰剂或无治疗相比的干预措施对计算机相关眼疲劳的疗效与安全性。未发现高确定性证据支持任何所分析疗法的使用,低确定性证据提示口服omega-3补充剂可减轻有症状计算机使用者的干眼症状。
要点
- 多焦点镜片与单光镜片相比未改善视疲劳评分(3项RCT;SMD 0.11;95%CI -0.14至0.37;P=0.38)。
- 蓝光阻隔眼镜未减少视疲劳症状(3项RCT),证据确定性低。
- 口服omega-3补充剂45天至3个月可改善干眼症状(2项RCT;MD -3.36;95%CI -3.63至-3.10;P<0.00001),证据确定性低。
核心结论
- 未发现高确定性证据支持所分析任何疗法的使用。
- 低确定性证据提示口服omega-3补充剂可减轻有症状计算机使用者的干眼症状。
研究设计与样本
- 系统评价与Meta分析,纳入45项随机对照试验,共4497名参与者。
- 检索Ovid MEDLINE、Embase、Cochrane对照试验中心注册库及试验注册库,从建库至2021年11月23日。
- 使用GRADE系统评估证据体确定性,不同量表测量合并时采用标准化均数差(SMD)。
主要发现
- 多焦点镜片与单光镜片相比未改善视疲劳评分(3项RCT;SMD 0.11;95%CI -0.14至0.37;P=0.38)。
- 蓝光阻隔眼镜未减少视疲劳症状(3项RCT),证据确定性低。
- 与安慰剂相比,口服浆果提取物补充剂未改善视疲劳(7项RCT;SMD -0.27;95%CI -0.70至0.16;P=0.22)或干眼症状(4项RCT;SMD -0.10;95%CI -0.54至0.33;P=0.65)。
- 口服omega-3补充剂45天至3个月与安慰剂相比改善干眼症状(2项RCT;MD -3.36;95%CI -3.63至-3.10,18单位量表;P<0.00001)。
- 口服类胡萝卜素补充剂与安慰剂相比改善临界闪烁融合频率(CFF)(2项RCT;MD 1.55 Hz;95%CI 0.42至2.67 Hz;P=0.007),尽管该发现的临床意义不明确。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未发现高确定性证据支持所分析任何疗法的使用。
- 蓝光阻隔眼镜减少视疲劳症状的证据确定性低。
- 口服类胡萝卜素补充剂改善CFF的临床意义不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
TOPIC: To evaluate the efficacy and safety of interventions for treating eye strain related to computer use relative to placebo or no treatment. CLINICAL RELEVANCE: Computer use is pervasive and often associated with eye strain, referred to as computer vision syndrome (CVS). Currently, no clinical guidelines exist to help practitioners provide evidence-based advice about CVS treatments, many of which are marketed directly to patients. This systematic review and meta-analysis was designed to help inform best practice for eye care providers. METHODS: Eligible randomized controlled trials (RCTs) were identified in Ovid MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, and trial registries, searched from inception through November 23, 2021. Eligible studies were appraised for risk of bias and were synthesized. The certainty of the body of evidence was judged using the Grading of Recommendations, Assessment, Development, and Evaluation system. Standardized mean differences (SMDs) were used when differently scaled measures were combined. RESULTS: Forty-five RCTs, involving 4497 participants, were included. Multifocal lenses did not improve visual fatigue scores compared with single-vision lenses (3 RCTs; SMD, 0.11; 95% confidence interval [CI], -0.14 to 0.37; P = 0.38). Visual fatigue symptoms were not reduced by blue-blocking spectacles (3 RCTs), with evidence judged of low certainty. Relative to placebo, oral berry extract supplementation did not improve visual fatigue (7 RCTs; SMD, -0.27; 95% CI, -0.70 to 0.16; P = 0.22) or dry eye symptoms (4 RCTs; SMD, -0.10; 95% CI, -0.54 to 0.33; P = 0.65). Likewise, berry extract supplementation had no significant effects on critical flicker-fusion frequency (CFF) or accommodative amplitude. Oral omega-3 supplementation for 45 days to 3 months improved dry eye symptoms (2 RCTs; mean difference [MD], -3.36; 95% CI, -3.63 to -3.10 on an 18 unit scale; P < 0.00001) relative to placebo. Oral carotenoid supplementation improved CFF (2 RCTs; MD, 1.55 Hz; 95% CI, 0.42 to 2.67 Hz; P = 0.007) relative to placebo, although the clinical significance of this finding is unclear. DISCUSSION: We did not identify high-certainty evidence supporting the use of any of the therapies analyzed. Low-certainty evidence suggested that oral omega-3 supplementation reduces dry eye symptoms in symptomatic computer users.
引用
- Singh S, McGuinness MB, Anderson AJ, et al. Interventions for the Management of Computer Vision Syndrome: A Systematic Review and Meta-analysis. Ophthalmology. 2022. PMID: 35597519. doi:10.1016/j.ophtha.2022.05.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。